5:48 PM
 | 
Feb 28, 2019
 |  BC Innovations  |  Translation in Brief

Targeting pathogenic Th17 cells

How two new autoimmune targets drive pathogenic Th17 activity

A recent pair of studies offers two new approaches to treating autoimmune diseases that go after the source of Th17-mediated inflammation.

T helper type 17 (Th17) cells are effector T cells that secrete the cytokine IL-17. Normal Th17 activity is required for host defense against pathogens, but hyperactivity leads to autoimmune disorders such as multiple sclerosis, psoriasis and rheumatoid arthritis.

This month, researchers at University...

Read the full 315 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$100 USD
More Info >